– the leading provider of online annual reports to individual and institutional investors.

Sucampo Pharmaceuticals, Inc.

Sucampo Pharmaceuticals, Inc., a bio-pharmaceutical company, focuses on the discovery, development, and commercialization of drugs based on prostones primarily in the Americas, Europe, and Asia. It offers prostone-based compounds for the treatment of gastrointestinal, vascular, respiratory, and central nervous system diseases and disorders.

No investor fact sheets added yet
No responsibility reports added yet

Browse Reports